НовостиBenzingaCantor Fitzgerald Reiterates Overweight on Artiva Biotherapeutics, Maintains $40 Price Target Cantor Fitzgerald Reiterates Overweight on Artiva Biotherapeutics, Maintains $40 Price Target Benzinga 2026.10.02 10:46 (GMT+0) Открыть на Benzinga Другие новости